Previous 10 | Next 10 |
Fulgent Genetics (NASDAQ: FLGT) stock absolutely skyrocketed throughout January and early February. But after shares rose more than 250%, Fulgent's momentum seemed to fizzle out. That fizzle is likely to return to a sizzle now, though. The genetic-testing company provided its fo...
Image source: The Motley Fool. Fulgent Genetics, Inc. Common Stock (NASDAQ: FLGT) Q4 2020 Earnings Call Mar 04, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Fulgent Genetics, Inc. Common Stock (FLGT) Q4 2020 Earn...
Fulgent Genetics, Inc. (FLGT) Q4 2020 Results Conference Call March 4, 2021 4:30 PM ET Company Participants Nicole Borsje - Head of Investor Relations Ming Hsieh - Chief Executive Officer Brandon Perthuis - Chief Commercial Officer Paul Kim - Chief Financial Officer Conference Call Participan...
Fulgent Genetics (FLGT): Q4 Non-GAAP EPS of $6.20 beats by $2.15; GAAP EPS of $6.16 beats by $2.09.Revenue of $294.9M (+3414.9% Y/Y) beats by $95.52M.2021 Outlook:Expects overall revenue of approximately $800.0 million ($600.22M consensus) in 2021, representing growth of 90% year-over-yearOf ...
Fourth Quarter 2020 Results : Record Revenue of $295.0 million, growing more than 3,400% year-over-year Record Billable tests delivered approximately 3.2 million, approximately 230 times the volume of fourth quarter of 2019 Gross Margin improved over 8 percentage points ...
[[AQN]], [[AVGO]], [[CERT]], [[CHUY]], [[COO]], [[COST]], [[FLGT]], [[GPS]], [[GWRE]], [[IMAX]], [[JAMF]], [[MANU]], [[MDLA]], [[OPEN]], [[PLYA]], [[SDC]], [[SWBI]], [[WORK]]For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Th...
CRISPR Therapeutics (NASDAQ: CRSP) and Fulgent Genetics (NASDAQ: FLGT) operate at different ends of the scientific gene pool. CRISPR, named for the Nobel Prize-winning CRISPR gene-editing technique, is a clinical-stage biotech company that is looking for gene-editing therapi...
Cases of, hospitalizations for, and deaths attributable to COVID-19 are finally dropping significantly. That's fantastic news for society at large, but it means the makers of coronavirus tests are going to see the eye-popping growth rates they put up in 2020 turn negative. Many are already ...
Moderna (NASDAQ: MRNA) , Teladoc Health (NYSE: TDOC) and Fulgent Genetics (NASDAQ: FLGT) have all had incredible runs over the last year. Moderna is up 570%. Teladoc stock has jumped 127%. And Fulgent has run up 500%. What's the strongest stock? Healthcare and Cannab...
Fulgent Genetics (NASDAQ: FLGT) has been a six-bagger over the past 12 months. Why is the stock running so high?Healthcare and Cannabis Bureau Chief Corinne Cardina and Fool contributor Taylor Carmichael discuss the bullish case for Fulgent Genetics. This segment was recorded live...
News, Short Squeeze, Breakout and More Instantly...
Fulgent Genetics Inc. Company Name:
FLGT Stock Symbol:
NASDAQ Market:
Fulgent Genetics Inc. Website:
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its second quarter 2024 financial results be...
2024-07-01 14:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-21 15:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...